SCHEMBL21749150

SCHEMBL21749150

Cc1nc2cc(-c3ccc(C(F)(F)F)cc3)nn2c(N2CCC[C@](C)(C(=O)O)C2)c1C(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.40
ABCB1 P08183 5/20 0.40
BTK Q06187 4/20 0.39
TSHR P16473 2/20 0.36
EIF2AK4 Q9P2K8 1/20 0.36
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36
MAPT P10636 4/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
CYP11B2 P19099 1/20 0.35
DGAT1 O75907 1/20 0.35
KCNH2 Q12809 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HPGD P15428 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSD17B10 Q99714 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21775864 1.00 ABCG2 (0.40) ABCG2ABCB1BTKTSHREIF2AK4
SCHEMBL21775744 1.00 ABCG2 (0.40) ABCG2ABCB1BTKTSHREIF2AK4
SCHEMBL21775646 0.90 ABCB1 (0.42) ABCG2ABCB1TSHRHCRTR1MAPT
SCHEMBL21775862 0.90 BTK (0.36) ABCG2ABCB1BTKEIF2AK4HCRTR1
SCHEMBL21775869 0.90 BTK (0.36) ABCG2ABCB1BTKEIF2AK4HCRTR1
SCHEMBL21775656 0.90 ABCG2 (0.40) ABCG2ABCB1BTKTSHRMAPT
SCHEMBL21775643 0.90 BTK (0.36) ABCG2ABCB1BTKEIF2AK4HCRTR1
SCHEMBL21775650 0.90 ABCG2 (0.40) ABCG2ABCB1BTKTSHRMAPT
SCHEMBL21774113 0.90 ABCB1 (0.43) ABCG2ABCB1TSHRMAPTALDH1A1
SCHEMBL21775601 0.89 ABCB1 (0.46) ABCG2ABCB1HCRTR1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives RICHTER GEDEON NYRT. (HU) 2021-03-30 US claimed
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives RICHTER GEDEON NYRT. (HU) 2020-02-27 US claimed
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives RICHTER GEDEON NYRT. (HU) 2021-03-30 US disclosed
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives RICHTER GEDEON NYRT. (HU) 2021-03-30 US disclosed
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives RICHTER GEDEON NYRT. (HU) 2020-02-27 US disclosed
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives RICHTER GEDEON NYRT. (HU) 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives GABRA5, P2RX5, P2RY1 ABCG2 136/4885ABCB1 243/4885BTK 2089/4885
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives GABRA5, P2RX5, P2RY1 ABCG2 136/4885ABCB1 243/4885BTK 2089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.